New Therapeutic Aspects of Inflammatory Cardiomyopathy

Author(s): Petr Kuchynka, Tomas Palecek, Eduard Nemecek, Michal Fikrle, Ales Linhart

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 4 , 2015

Become EABM
Become Reviewer
Call for Editor


Inflammatory cardiomyopathy is a term used for left ventricular systolic dysfunction associated with myocarditis. In order to establish definitely the diagnosis, an endomyocardial biopsy (EMB) must be performed. Based on the results of EMB analysis, specific treatment may be added to conventional heart failure therapy. Immunosuppressive therapy in patients with non-viral inflammatory cardiomyopathy has been shown to be effective, and there is also some evidence that antiviral or antimicrobial therapy may be beneficial.

Keywords: Myocarditis, inflammatory cardiomyopathy, endomyocardial biopsy, immunosuppression, antimicrobial treatment.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [459 - 465]
Pages: 7
DOI: 10.2174/138161282104141204142244
Price: $65

Article Metrics

PDF: 41